Glenn Baity - Net Worth and Insider Trading
Glenn Baity Net Worth
The estimated net worth of Glenn Baity is at least $1 Million dollars as of 2025-04-11. Glenn Baity is the EVP AND GC of ACADIA Pharmaceuticals Inc and owns about 83,734 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $1 Million. Details can be seen in Glenn Baity's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Glenn Baity has not made any transactions after 2018-01-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Glenn Baity
Glenn Baity Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Glenn Baity owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Glenn Baity’s form 4 insider trades.
Insider Ownership Summary of Glenn Baity
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2018-01-29 | VP & GC & Sec. |
Glenn Baity Latest Holdings Summary
Glenn Baity currently owns a total of 1 stock. Glenn Baity owns 83,734 shares of ACADIA Pharmaceuticals Inc (ACAD) as of January 29, 2018, with a value of $1 Million.
Latest Holdings of Glenn Baity
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2018-01-29 | 83,734 | 14.11 | 1,181,487 |
Holding Weightings of Glenn Baity
Glenn Baity Form 4 Trading Tracker
According to the SEC Form 4 filings, Glenn Baity has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 36,558 shares on January 29, 2018, which brought Glenn Baity around $1 Million.
Insider Trading History of Glenn Baity
- 1
Glenn Baity Trading Performance
Glenn Baity Ownership Network
Ownership Network List of Glenn Baity
Ownership Network Relation of Glenn Baity
Glenn Baity Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
Glenn Baity is the VP & GC & Sec. of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include Chief Financial Officer Mark C. Schneyer , Principal Accounting Officer James Kihara , and EVP & COO & Head of Commercial Brendan Teehan .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, Glenn Baity made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 45,152 shares made by Mark C. Schneyer , a net sale of 14,246 shares made by James Kihara , and a net sale of 37,363 shares made by Brendan Teehan .
In summary, during the past 3 months, insiders sold 14,169 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 14,169 shares. During the past 18 months, 199,041 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 199,041 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
Glenn Baity Mailing Address
Above is the net worth, insider trading, and ownership report for Glenn Baity. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Glenn Baity's mailing address is: San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
